Tours, France and California, USA (January 17, 2022) –
TSC Endovision, a pioneer in single-use endoscopy and part of TSC Group, and Flexicare, a leading manufacturer and supplier of medical devices, announce today an exclusive partnership for the distribution of TSC Endovision’s Broncoflex™, an innovative single-use bronchoscope, in the US market.
The endoscopy market landscape continues to evolve as regulatory bodies across the globe recommend single-use technology to reduce cross-contamination risk and improve patient outcomes. The latest version of the Broncoflex™ product range was commercially launched in European markets in 2020. The Broncoflex solution is a fully sterile, cost-effective, ergonomically designed solution, requiring only two sizes that cover all flexible bronchoscopy therapeutic indications. The Parties are thrilled to now also make this innovative technology available to US healthcare providers.
From Luc Van Schil, CEO and founder of TSC, “We are pleased to announce an exclusive partnership with Flexicare for the US market. This collaboration brings together leading-edge endoscopy technology with a high-performing and experienced commercial US organization. This will allow for a promising Broncoflex US market introduction and will support healthcare’s transition to single-use endoscopy.”
With over 2.5 million bronchoscopy procedures performed each year in the US, TSC Endovision and Flexicare are well positioned to bring the Broncoflex to the largest endoscopy market and support acute care physicians with a single-use technology that will meet their flexible bronchoscopy needs.
“The addition of the Broncoflex technology to the Flexicare portfolio further supports our commitment to bring innovative, high-quality technologies that meet and exceed the needs of healthcare professionals and improve patient outcomes. We are proud to partner with TSC Endovision in bringing this next level technology to the US market,” states Ghassem Poormand, CEO and founder of Flexicare.
About TSC Endovision
TSC Endovision has been developing ergonomically designed, single-use flexible endoscopes for more than 10 years and the Broncoflex™ is currently sold in over 30 countries worldwide. The company’s ambition is to provide easy-to-use solutions adapted to the needs of health care professionals for the benefit of patients. TSC Endovision is part of The Surgical Company (TSC) Group, which is a privately owned Medtech group employing around 500 people and headquartered in The Netherlands with operations in France, Benelux, Germany and the UK.
For more information about the Broncoflex from TSC Endovision, please click here.
About Flexicare
Flexicare is a privately owned, leading designer, manufacturer and supplier of medical devices with over 30 years of experience in the healthcare sector. With an international presence in over 100 countries, supported by its subsidiaries across the US, Europe, Middle East, Africa, India, Asia and Australia, Flexicare has built a reputation as an innovator in the airway management, anaesthesia and respiratory field.
For more information about Flexicare, please click here.
We are delighted to announce that our direct sales force will now support the complete TSC Life product portfolio direct in the UK, which means that with a UK based…
Read article
Launch of TSC Life through the merger of the surgical company’s patient temperature management and single-use endoscopy businesses. Amersfoort, the Netherlands, 30 January 2024 The Surgical Company is excited to…
Read article
From 29 January to 1 February 2024, The Surgical Company Endovision is excited to be attending the Arab Health in Dubai. Our enthusiastic teams will be at booth #S3.C58 .…
Read articleSubscribe to our monthly newsletter containing the latest updates and developments of The Surgical Company
